Long-term prognostic value of big endothelin-1 and its combination with late gadolinium enhancement in patients with idiopathic restrictive cardiomyopathy.

MLA

Qu, Yi, et al. “Long-Term Prognostic Value of Big Endothelin-1 and Its Combination with Late Gadolinium Enhancement in Patients with Idiopathic Restrictive Cardiomyopathy.” Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 561, July 2024, p. 119755. EBSCOhost, https://doi.org/10.1016/j.cca.2024.119755.

APA

Qu, Y., Zhang, D., Hu, Y., Wang, J., Tan, H., Qin, F., & Liu, Y. (2024). Long-term prognostic value of big endothelin-1 and its combination with late gadolinium enhancement in patients with idiopathic restrictive cardiomyopathy. Clinica Chimica Acta; International Journal of Clinical Chemistry, 561, 119755. https://doi.org/10.1016/j.cca.2024.119755

Chicago

Qu, Yi, Di Zhang, Yuxiao Hu, Jiayi Wang, Huiqiong Tan, Fuzhong Qin, and Yaxin Liu. 2024. “Long-Term Prognostic Value of Big Endothelin-1 and Its Combination with Late Gadolinium Enhancement in Patients with Idiopathic Restrictive Cardiomyopathy.” Clinica Chimica Acta; International Journal of Clinical Chemistry 561 (July): 119755. doi:10.1016/j.cca.2024.119755.